Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study
Abstract Zinc inhibits intestinal copper uptake, an effect utilized for treating Wilson’s disease (WD). We used copper-64 (64Cu) PET/CT to examine how much four weeks of treatment with different zinc regimens reduced the hepatic 64Cu content after oral 64Cu administration and test if alternative reg...
Main Authors: | Ditte Emilie Munk, Tea Lund Laursen, Frederik Teicher Kirk, Hendrik Vilstrup, Aftab Ala, Lars Christian Gormsen, Peter Ott, Thomas Damgaard Sandahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-18872-8 |
Similar Items
-
Distribution of non-ceruloplasmin-bound copper after i.v. 64Cu injection studied with PET/CT in patients with Wilson disease
by: Ditte Emilie Munk, et al.
Published: (2023-11-01) -
Case report: Huppke–Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years
by: Frederik Teicher Kirk, et al.
Published: (2022-09-01) -
Edging closer to successful gene therapy for Wilson disease
by: Thomas Damgaard Sandahl, et al.
Published: (2022-12-01) -
Zinc Maintenance Therapy for Wilson Disease: A Comparison Between Zinc Acetate and Alternative Zinc Preparations
by: Michelle A. Camarata, et al.
Published: (2019-08-01) -
Serum copper, zinc, and copper − zinc ratio in children with malaria
by: Belinda Onosen Jimoh, et al.
Published: (2022-01-01)